title: Is there an optimal thrombolytic regimen?
authors.affiliation: Center for Molecular and Vascular Biology, University of Leuven, Belgium.
authors.forename: D
authors.initials: D
authors.lastname: Collen
mesh_terms: D000818:Animals; D002986:Clinical Trials as Topic; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*; D013300:Streptokinase / Q000627:therapeutic use; D015912:Thrombolytic Therapy; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use
chemical_list: D005343:Fibrinolytic Agents; D013300:Streptokinase; D010959:Tissue Plasminogen Activator